IBS(SH:603183)2022-04-29 16:00Financial Performance - The company's operating revenue for Q1 2022 was ¥140,111,396.14, a decrease of 0.17% compared to the same period last year[4] - The net profit attributable to shareholders was -¥10,178,225.44, representing a decline of 207.04% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥11,399,194.89, a decrease of 248.98% compared to the previous year[4] - The net profit for Q1 2022 was -7,765,522.75 RMB, a significant decline compared to a net profit of 10,463,538.20 RMB in Q1 2021, representing a year-over-year decrease of approximately 174.3%[17] - Operating profit for Q1 2022 was -8,180,849.95 RMB, compared to an operating profit of 10,589,489.21 RMB in the same period last year, indicating a decline of around 177.3%[17] - Total comprehensive income for Q1 2022 was -7,765,522.75 RMB, compared to 10,463,538.20 RMB in Q1 2021, marking a decline of approximately 174.3%[18] Cash Flow - The net cash flow from operating activities was -¥79,453,760.36, indicating a significant cash outflow[4] - Cash flow from operating activities showed a net outflow of -79,453,760.36 RMB in Q1 2022, worsening from -49,623,327.16 RMB in Q1 2021[20] - The company reported a cash balance of $29,818,758.82 at the end of the quarter, down from $79,046,823.99 at the beginning of the period[32] - Total cash inflow from operating activities was $2,752,767.04, while cash outflow was $59,081,324.68, resulting in a negative cash flow[31] - The total cash and cash equivalents decreased by $49,228,065.17 during the quarter[32] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,760,815,282.05, down 7.24% from the end of the previous year[4] - Total current assets decreased to CNY 851,818,894.16 as of March 31, 2022, down from CNY 1,005,762,324.29 at the end of 2021[14] - Total liabilities decreased to CNY 328,638,035.04 in Q1 2022, down from CNY 458,197,770.81 in Q1 2021[15] - The company's equity attributable to shareholders was CNY 1,393,624,769.88, down from CNY 1,409,474,390.67 year-over-year[16] - Total current liabilities decreased from CNY 375,714,555.66 to CNY 333,703,165.87, a decline of about 11.2%[24] Operational Challenges - The company faced operational impacts due to local COVID-19 restrictions starting from February 14, affecting production[11] - The company reported a significant increase in financial expenses by 75.43%, primarily due to unrecognized financing costs related to leasing assets[6] Expenses - Total operating costs increased to CNY 157,659,423.52 in Q1 2022, up 12.8% from CNY 139,873,766.34 in Q1 2021[16] - Operating expenses included CNY 84,792,681.46 in cost of goods sold, which rose from CNY 72,406,268.03 in the previous year[16] - Research and development expenses for Q1 2022 were CNY 18,783,425.59, slightly higher than CNY 18,462,148.78 in Q1 2021[16] - The company incurred a total operating expense of 291,926,483.46 RMB in Q1 2022, compared to 281,281,976.16 RMB in Q1 2021, reflecting an increase of approximately 3.1%[20] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 47,069[9] - The basic and diluted earnings per share for Q1 2022 were both -0.02 RMB, compared to 0.03 RMB in Q1 2021, indicating a significant decline[18]